Remote Patient Monitoring Devices Patent Landscape Analysis Report 2026 Edition

Remote Patient Monitoring Devices Market Size, Growth Trends, and Industry Outlook

Remote patient monitoring devices collect physiological data from patients outside hospital walls and transmit it to clinical teams for review. Typical kits combine blood pressure cuffs, pulse oximeters, glucose meters, weight scales, cardiac patches and cellular gateways, increasingly joined by consumer smartwatches and rings. Programmes concentrate on chronic cardiometabolic disease, post-discharge recovery and high-risk pregnancy, where daily readings let clinicians adjust therapy before a hospital visit becomes necessary.

The market growth is driven by Medicare payment for home-collected data, which pulled close to 1 million enrollees into monitoring programmes in 2024 with payments above USD 500 million according to the HHS Office of Inspector General. The US Centers for Disease Control and Prevention reports that 6 in 10 American adults live with at least one chronic disease, which sustains a large pool of patients eligible for daily readings.

The 2026 Medicare physician fee schedule added codes for device supply covering 2 to 15 days of data and for 10 to 19 minutes of monthly management, so practices can bill for patients who fall short of the earlier 16-day threshold. That change widens the eligible patient base and lifts demand for low-cost, cellular-connected kits that transmit without setup. The Inspector General review that found almost half of enrollees received an incomplete service bundle adds pressure for devices with automatic transmission and audit trails. Apple received FDA clearance for hypertension notifications in September 2025, which shows consumer sensors producing data that clinical programmes can absorb.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Remote Patient Monitoring Devices Patent Filing Trends and Innovation Activity

Patent filing in remote patient monitoring devices has moved from stand-alone home meters toward connected sensor systems with embedded analytics. Early families covered telehealth carts, modem-based scales and telemetry transmitters. Recent filings address adhesive biosensor patches, cuffless blood pressure estimation, low-power cellular modules and algorithms that rank alerts by clinical urgency.

The dataset holds about 8,740 patent families, with filing peaks in 2014 to 2016 around smartphone-linked sensors and a sharper rise from 2020 after pandemic-era home monitoring programmes scaled. United States filers hold the most heavily cited claims on cardiac and alert algorithms, while Chinese manufacturers contribute rising volume on wearable hardware.

Reimbursement growth and the shift of chronic care to the home appear in the patent record as sustained filing on connected patches, cuffless sensing and alert triage.

Scope of the Remote Patient Monitoring Devices Patent Landscape Analysis Report

This report covers granted patents and published applications on devices that measure physiological signals outside clinical facilities and transmit them to care teams. It includes cardiac, blood pressure, glucose, respiratory and multiparameter monitors, along with gateways, firmware and data pipelines tied to those devices.

Coverage spans sensor hardware, wearable form factors, signal processing, connectivity modules and monitoring workflows. Entries are consolidated by patent family and tracked by assignee, priority year, jurisdiction and technology cluster.

The assignee analysis includes medical device makers, consumer electronics firms, monitoring service companies, health systems and universities that hold remote patient monitoring devices families.

Global Remote Patient Monitoring Devices Patent Landscape Analysis

Remote Patient Monitoring Devices Patent Filing Trend Analysis

Filing volume for remote patient monitoring devices grew at an estimated annual rate of about 11% between 2020 and 2024. Growth came from pandemic-driven home care programmes, consumer electronics firms adding clinical-grade sensing to watches and rings, and Chinese manufacturers filing on patches and hub devices.

Grants in 2025 reached roughly 855 patents, a modest share of the more than 3,760 patents linked to the primary jurisdiction. Examiners cite dense prior art on pulse and blood pressure sensing, so applicants increasingly draft claims around calibration methods, motion artefact handling and alert logic.

Leading Companies and Assignee Analysis in the Remote Patient Monitoring Devices Patent Landscape

Geographic Analysis of Remote Patient Monitoring Devices Patent Activity

The report assesses patent activity across major jurisdictions, including:

• United States
• Europe
• China
• Japan
• South Korea
• India
• International and WIPO filings

The United States leads by filing volume and citation strength, shaped by Medicare reimbursement and FDA clearance pathways. China follows with manufacturing-led filings on wearable patches, oximeters and home hubs. Europe ranks third, anchored by Philips and cardiology device makers, and its filings concentrate on cardiac telemetry and alert algorithms.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Remote Patient Monitoring Devices Technology Segmentation and Innovation Areas

The technology segments covered in this report include:

• Wearable multiparameter biosensor patches
• Insertable and implantable cardiac monitors
• Cuffless blood pressure and smartwatch sensing
• Cellular home hub gateways and connectivity modules
• Alert triage and deterioration scoring algorithms

Among these, wearable multiparameter biosensor patches and smartwatch sensing account for the largest share of patent families because consumer and medical manufacturers both file on adhesive and wrist-worn form factors.

Competitive Landscape and Emerging Trends in the Remote Patient Monitoring Devices Market

Competition spans hospital monitoring incumbents, cardiac device makers and consumer electronics firms. Koninklijke Philips and GE HealthCare combine bedside and home monitoring, Medtronic dominates insertable cardiac monitors, and Samsung Electronics and Apple file on wrist sensors with growing regulatory clearances. Acquisitions of monitoring service providers are a recurring route to recurring revenue.

Companies are focusing on:

• Adhesive biosensor patches with multi-day battery life
• Insertable cardiac monitors with atrial fibrillation detection
• Cuffless blood pressure estimation from optical sensors
• Cellular gateways that transmit without home broadband
• Alert prioritisation to reduce clinician review burden
• Medication adherence and weight sensing for heart failure
• Data integrity and audit trails for reimbursement compliance

Emerging innovation themes include smart rings with clinical-grade sensing, cuffless hypertension screening on watches, and continuous glucose and blood pressure data merged in one dashboard. Edge algorithms that filter noise on the device before transmission are drawing early filings. Remote monitoring kits for high-risk pregnancy and post-surgical recovery are also growing in claim count.

Strategic Insights from the Remote Patient Monitoring Devices Patent Landscape

The competitive position in remote patient monitoring devices depends on sensor accuracy claims, algorithm clearance status and integration with reimbursement workflows. Medical device incumbents hold clearance experience, while consumer electronics firms hold scale and user bases. New value is shifting toward alert triage and compliance-ready data capture.

Technology segments, assignee positions and jurisdictional trends in remote patient monitoring devices are analysed in nine areas, and the report provides actionable intelligence supporting:

• Intellectual property strategy
• R&D prioritisation
• Competitive benchmarking
• Technology scouting
• Licensing evaluation
• Partnership assessment
• Investment analysis
• Market entry planning
• Portfolio expansion strategy

Research Methodology for the Remote Patient Monitoring Devices Patent Landscape Analysis

The study searches patent databases at the USPTO, the European Patent Office, the China National Intellectual Property Administration, the Korean Intellectual Property Office, the Japan Patent Office and WIPO PATENTSCOPE. Records cover publications from 2000 to 2025.

Queries combine keywords on remote monitoring, telemetry, wearable sensors, home hubs and cuffless measurement with CPC classes A61B 5/00, A61B 5/0205, A61B 5/021 and G16H 40/67, plus IPC A61B 5/02 and H04W 4/38. Results are screened manually, deduplicated and consolidated at patent family level before assignee normalisation.

The market side draws on FDA and EMA clearance records, Medicare fee schedule rules, company filings, clinical trial registries and peer-reviewed literature. Patent trends are cross-checked against product launches and reimbursement changes.

Related Reports

AI in Remote Patient Monitoring Market

United States Remote Therapeutic Monitoring Market

Prenatal Monitoring Devices Patent Landscape Analysis